Literature DB >> 6149697

Release of somatostatinlike immunoreactivity from canine fundic mucosal cells in primary culture.

A H Soll, T Yamada, J Park, L P Thomas.   

Abstract

We have developed a model to allow study of the release of somatostatinlike immunoreactivity (SLI) from gastric mucosal cells. Collagenase-dispersed canine fundic mucosal cells were separated by counterflow elutriation. SLI-containing cells were identified in the fractions with small cells (9-11 microns), and these fractions were plated onto collagen. After 2 days in culture, SLI content of the cells was maintained; SLI-positive cells, detected by peroxidase-antiperoxidase immunohistochemistry, comprised 70 +/- 6% (mean +/- SE, n = 6) of these cultured cells. Release of SLI from these cultures into the medium was determined by radioimmunoassay. Epinephrine, dibutyryl cAMP, and gastrin each stimulated SLI release in a time-dependent manner, with a steady rate of secretion maintained for 120 min of incubation. Both epinephrine and dibutyryl cAMP markedly potentiated the release of SLI stimulated by gastrin but were not themselves mutually potentiating. Upon Sephadex G-50 column chromatography of incubation medium and extracts of cultured cells, SLI eluted primarily in a single peak that cochromatographed with synthetic somatostatin tetradecapeptide. Our data suggest that gastrin and adrenergic stimuli act directly on canine fundic somatostatin cells and that potentiating interactions between secretagogues may be important modulating elements in somatostatin cell secretory function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6149697     DOI: 10.1152/ajpgi.1984.247.5.G558

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

Review 1.  Gastrin-histamine sequence in the regulation of gastric acid secretion.

Authors:  H L Waldum; A K Sandvik; E Brenna; H Petersen
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

2.  Polarized intestinal hybrid cell lines derived from primary culture: establishment and characterization.

Authors:  G W Aponte; A Keddie; G Halldén; R Hess; P Link
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

3.  Gastric luminal somatostatin secretion of normals and patients with pernicious anemia and with Zollinger-Ellison syndrome.

Authors:  A Ertan; A Ozden; E Golodner; H Degertekin; A Arimura
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

4.  Immunocytochemical characterization of monoclonal antibody A2B5 in the rat gastric antrum.

Authors:  T Azuma; K Kawai; J H Walsh
Journal:  Gastroenterol Jpn       Date:  1987-12

5.  Biosynthesis of somatostatin in canine fundic D cells.

Authors:  T Chiba; J Park; T Yamada
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

6.  Stimulation of gastrin release by bombesin and canine gastrin-releasing peptides. Studies with isolated canine G cells in primary culture.

Authors:  K Sugano; J Park; A H Soll; T Yamada
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

7.  Effect of sympathomimetics on gastrin secretion from antral G cells in culture.

Authors:  A M Buchan
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

8.  [Isolated human gastric mucosa cells--studies on physiologic and pharmacologic regulatory mechanisms].

Authors:  W Schepp; S E Miederer; H J Ruoff; U Wulfhekel
Journal:  Klin Wochenschr       Date:  1986-01-02

9.  Treatment of Helicobacter gastritis with IL-4 requires somatostatin.

Authors:  Yana Zavros; Sivaprakash Rathinavelu; John Y Kao; Andrea Todisco; John Del Valle; Joel V Weinstock; Malcolm J Low; Juanita L Merchant
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-10       Impact factor: 11.205

10.  Differential control of somatostatin messenger RNA in rat gastric corpus and antrum. Role of acid, food, and capsaicin-sensitive afferent neurons.

Authors:  A K Sandvik; R Dimaline; E R Forster; D Evans; G J Dockray
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.